title: Chinese health biotech and the billion-patient market.
authors.affiliation: McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario, M5G 1L7, Canada.
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Frew
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Sammut
authors.forename: Alysha F
authors.initials: AF
authors.lastname: Shore
authors.forename: Joshua K
authors.initials: JK
authors.lastname: Ramjist
authors.forename: Sara
authors.initials: S
authors.lastname: Al-Bader
authors.forename: Rahim
authors.initials: R
authors.lastname: Rezaie
authors.forename: Abdallah S
authors.initials: AS
authors.lastname: Daar
authors.forename: Peter A
authors.initials: PA
authors.lastname: Singer
mesh_terms: D020811:Biomedical Technology / Q000639:trends*; D001709:Biotechnology / Q000639:trends*; D002681:China; D003695:Delivery of Health Care / Q000639:trends*; D004345:Drug Industry / Q000639:trends*; D008389:Marketing of Health Services / Q000639:trends*